Literature DB >> 19215755

Chapter 5. In vivo analysis of the decay of transcripts generated by cytoplasmic RNA viruses.

Nicole L Garneau1, Carol J Wilusz, Jeffrey Wilusz.   

Abstract

The field of RNA decay has grown extensively over the last few years and numerous decay pathways have been identified and characterized. This is a truly powerful machinery for both regulation and quality control of gene expression. It is very likely that the transcripts of RNA viruses must successfully confront this arsenal of enzymes and RNA binding factors in order to establish a productive infection. This interface is an understudied branch of virology that needs to be explored if we are to fully comprehend the molecular biology of virus-cell interactions. Research in this area has the potential to increase our understanding of the fundamentals of both mRNA stability and viral biology, perhaps leading to novel antiviral approaches. This chapter discusses methods for examining the half-lives of viral RNAs during natural infection, including purification of the viral transcripts and subsequent analysis of both deadenylation and decay. Additionally, a hybrid selection protocol for identifying viral-specific small RNAs that are generated during infection by the RNAi branch of the cellular RNA decay machinery is described.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19215755     DOI: 10.1016/S0076-6879(08)02405-1

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  2 in total

1.  The PARN deadenylase targets a discrete set of mRNAs for decay and regulates cell motility in mouse myoblasts.

Authors:  Jerome E Lee; Ju Youn Lee; Jarrett Trembly; Jeffrey Wilusz; Bin Tian; Carol J Wilusz
Journal:  PLoS Genet       Date:  2012-08-30       Impact factor: 5.917

2.  Sequences encoding C2H2 zinc fingers inhibit polyadenylation and mRNA export in human cells.

Authors:  Joseph Russo; Aimee L Jalkanen; Adam M Heck; Caleb M Schmidt; Jeffrey Wilusz; Carol J Wilusz
Journal:  Sci Rep       Date:  2018-11-19       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.